arrow
V

Virginie Westeel

inserm umr1098 right
H指数:49
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Response to letter Re: “Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS”

回复函:关于“吗啡和二甲双胍影响非小细胞肺癌患者免疫治疗效果:IFCT-1502 CLINIVO-SNDS真实世界研究的结果”

2025-07-300
PRE
Adjuvant chemotherapy for stage IA–IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial

根据14基因表达谱被鉴定为分子高危的IA–IIA期非鳞状、非小细胞肺癌的辅助化疗(AIM-HIGH):一项国际、随机、III期临床试验

2025-06-240
OAAI
Morphine and metformin impact immunotherapy benefit in patients with NSCLC: Results of the real-world study IFCT-1502 CLINIVO-SNDS

吗啡和二甲双胍影响NSCLC患者免疫治疗效果:IFCT-1502 CLINIVO-SNDS真实世界研究的结果

2025-06-110
PRE
High risk of lung cancer in surfactant-related gene variant carriers
2024-04-040
OAAI
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial
LANCET
IF88.5
2023-12-0113
PRE
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study
2023-01-017
OAAI
Prevalence and Characteristics of Sleep Apnea in Intensive Care Unit Survivors After SARS-CoV-2 Pneumonia
2022-12-013
OAAI
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort

Lorlatinib治疗晚期间变性淋巴瘤激酶阳性非小细胞肺癌: IFCT-1803 LORLATU队列的结果

2022-05-0117
OAAI
Result of one-year, prospective follow-up of intensive care unit survivors after SARS-CoV-2 pneumonia

SARS CoV-2肺炎后重症监护病房幸存者的一年前瞻性随访结果

2022-03-0938
OAAI
Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network
2022-02-018
OAAI
Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients

COVID-19-positive患者SARS-CoV-2-specific免疫T细胞反应的研究

2021-06-0121
OAAI
Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer

单一或联合免疫检查点抑制剂与一线铂类化疗联合或不联合贝伐单抗治疗晚期非小细胞肺癌的比较

2021-04-3034
OAAI